Role of MRD in elderly acute myeloid leukemia | CIA
Frontiers | MRD Tailored Therapy in AML: What We Have Learned So Far
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients | Haematologica
a Minimal residual disease (MRD) in acute myeloid leukemia (AML) using... | Download Scientific Diagram
Measurable residual disease measurement methods in acute myeloid leukaemia. | Download Scientific Diagram
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party - ScienceDirect
The present and future of measurable residual disease testing in acute myeloid leukemia | Haematologica
MRD evaluation during treatment of AML patients according to ELN... | Download Scientific Diagram
NGS rEvolution - Minimal Residual Disease Detection
Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) | FNIH
JCM | Free Full-Text | Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia - Biology of Blood and Marrow Transplantation
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia | Leukemia
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML) | Leukemia
MRD Tailored Therapy in AML: What We Have Learned So Far. - Abstract - Europe PMC
Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
Frontiers | Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?
MRD assessment in different therapeutic stadia of AML. | Download Scientific Diagram
What Is the Measure of Minimal Residual Disease in AML - The ASCO Post
Minimal Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia | IntechOpen
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party - ScienceDirect
Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
Biomedicines | Free Full-Text | Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions
What is Measurable Residual Disease (MRD) | CatALLyst™
